EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, operating in the U.S. and Canada, has announced a landmark agreement with the administration of President Donald J. Trump to broaden access to in vitro fertilization (IVF) therapies for the…
Ferring Pharmaceuticals has announced additional real-world evidence from a private urology practice evaluating the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC), specifically those with carcinoma in situ (CIS)…
Samsara Vision, a company dedicated to restoring vision and independence to patients living with late-stage, age-related macular degeneration (AMD) through advanced visual prosthetic devices, today announced the expansion of its ongoing Concerto clinical study evaluating the investigational Smaller-Incision New-Generation Implantable…
eClinical Solutions LLC, a global provider of digital clinical software and services, today announced a strategic partnership with ZS, a leading global management consulting and technology firm, to deliver an enhanced risk-based quality management (RBQM) offering tailored for the life…
Roquette, a global leader in plant-based ingredients and pharmaceutical excipients across the health, nutrition, and bioindustrial sectors, today announced the grand opening of its dedicated Health & Pharma Solutions Innovation Center in São Paulo, Brazil. The state-of-the-art facility marks a…
WISEcode™, the FoodTechAI™ company on a mission to deliver precision transparency in food, today announced the launch of WISEscore™, the first unified food score that merges ingredient quality and nutrient quality into a single, powerful metric. Now available in the…
ME Therapeutics Holdings Inc., a publicly listed biotechnology company focused on developing innovative cancer therapies in the field of immuno-oncology, today announced a significant milestone in its in vivo CAR cell therapy program. The Company’s subsidiary, ME Therapeutics Inc., has…
Y.ora Vision, Inc., a newly established ophthalmic medical device company and a spoke company of Eyexora, has officially announced the signing of a licensing agreement between the Singapore Eye Research Institute (SERI) and Eyexora Global. The agreement is set to…
hape Memory Medical Inc., developer of the only commercially available volume-expanding shape memory polymer for endovascular embolization, has announced that it has reached 50% enrollment in its ongoing AAA-SHAPE Pivotal Trial. This milestone marks the successful treatment of the 90th…
Delix Therapeutics, a clinical-stage neuroscience company advancing a new generation of non-hallucinogenic neuroplastogens for the treatment of serious neuropsychiatric and neurodegenerative disorders, has announced the publication of a peer-reviewed study in ACS Chemical Neuroscience. The paper, titled “Zalsupindole is a…